Study of doxorubicin induced cardiac dysfunction in children with cancer

Study of doxorubicin induced cardiac dysfunction in children with cancer

Bibliographic Details
Main Authors:	Radhika jatana, B.P. Kalra
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124522004168

Similar Items

Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity
by: Sibren Haesen, et al.
Published: (2024-01-01)

Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.
by: Yuan Zhang, et al.
Published: (2011-01-01)

Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition
by: Ryan N. Montalvo, et al.
Published: (2020-10-01)

Mitochondrial transplantation ameliorates doxorubicin-induced cardiac dysfunction via activating glutamine metabolism
by: Xiaolei Sun, et al.
Published: (2023-10-01)

Calcitriol Attenuates Doxorubicin-Induced Cardiac Dysfunction and Inhibits Endothelial-to-Mesenchymal Transition in Mice
by: Tzu-Hsien Tsai, et al.
Published: (2019-08-01)

Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: An in vivo study
by: Farshid Maleki, et al.
Published: (2023-12-01)

NADPH oxidase 2 mediates cardiac sympathetic denervation and myocyte autophagy, resulting in cardiac atrophy and dysfunction in doxorubicin-induced cardiomyopathy
by: Yuan Ma, et al.
Published: (2024-03-01)

Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin
by: Seon-Hwa Lee, et al.
Published: (2022-05-01)

Assessment of left heart dysfunction to predict doxorubicin cardiotoxicity in children with lymphoma
by: Jiaqi Chen, et al.
Published: (2023-05-01)

Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer
by: Kevin J Lee, et al.
Published: (2021-07-01)

Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-caused Cardiac Dysfunction through Inhibition of Cardiac Fibrosis and Inflammation
by: Hsin-Lun Yang, et al.
Published: (2020-04-01)

Naringenin Regulates Doxorubicin-Induced Liver Dysfunction: Impact on Oxidative Stress and Inflammation
by: Adil Farooq Wali, et al.
Published: (2020-04-01)

Prevention of Doxorubicin-Induced Autophagy Attenuates Oxidative Stress and Skeletal Muscle Dysfunction
by: Vivian Doerr, et al.
Published: (2020-03-01)

RETRACTED: MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway
by: Runze Wang, et al.
Published: (2021-04-01)

Retraction: MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway
by: Frontiers Editorial Office
Published: (2022-08-01)

Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice
by: Araceli Lérida-Viso, et al.
Published: (2022-09-01)

Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children
by: Mohamed Hegazy, et al.
Published: (2023-01-01)

Semaglutide attenuates doxorubicin-induced cardiotoxicity by ameliorating BNIP3-Mediated mitochondrial dysfunction
by: Xiaoping Li, et al.
Published: (2024-06-01)

Management of Advanced Heart Failure in Children with Cancer Therapy-Related Cardiac Dysfunction
by: Hari P. Tunuguntla, et al.
Published: (2021-09-01)

Systemic and cardiac susceptibility of immune compromised mice to doxorubicin
by: Amanda J. Favreau-Lessard, et al.
Published: (2019-04-01)

The Protective Role of Glutathione against Doxorubicin-Induced Cardiotoxicity in Human Cardiac Progenitor Cells
by: Eun Ji Lee, et al.
Published: (2023-07-01)

Higenamine Attenuates Doxorubicin-Induced Cardiac Remodeling and Myocyte Apoptosis by Suppressing AMPK Activation
by: Cuiliu Jin, et al.
Published: (2022-05-01)

Cardiac dysfunctions in children with drug-resistant epilepsy
by: Watthana Sridech, et al.
Published: (2024-04-01)

Extract of Prevents Doxorubicin-induced Cardiotoxicity in Breast Cancer
by: Youyang Shi MD, PhD, et al.
Published: (2023-04-01)

Cardiac autonomic dysfunction in obese normotensive children and adolescents
by: Isabelle Magalhães G. Freitas, et al.
Published: (2014-06-01)

The Genetic Evidence of Burn-Induced Cardiac Mitochondrial Metabolism Dysfunction
by: Jake J. Wen, et al.
Published: (2020-12-01)

Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons
by: Nicola Moro, et al.
Published: (2022-09-01)

Doxorubicin-dependent skeletal muscle atrophy: exercise and mitochondrial dysfunction
by: Gökhan Burçin Kubat, et al.
Published: (2024-02-01)

Recent Advances in the Mechanisms of Cell Death and Dysfunction in Doxorubicin Cardiotoxicity
by: Tian-Hu Wang, et al.
Published: (2023-11-01)

Lithium Treatment Induces Cardiac Dysfunction in Mice
by: Serena L’Abbate, et al.
Published: (2023-11-01)

Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo/YAP-Mediated Apoptosis
by: Rong-Hua Tao, et al.
Published: (2021-06-01)

Inhibition of ADAM10 ameliorates doxorubicin-induced cardiac remodeling by suppressing N-cadherin cleavage
by: Li Xiaoou, et al.
Published: (2021-08-01)

Integration of transcriptomics, metabolomics, and lipidomics reveals the mechanisms of doxorubicin-induced inflammatory responses and myocardial dysfunction in mice
by: Xin Tan, et al.
Published: (2023-06-01)

Astragaloside IV Inhibits NLRP3 Inflammasome-Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction
by: Xueheng Chen, et al.
Published: (2023-03-01)

Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
by: Xin-Ru Li, et al.
Published: (2022-08-01)

Early detection of doxorubicin-induced cardiotoxicity in rats by its cardiac metabolic signature assessed with hyperpolarized MRI.
by: Timm, KN, et al.
Published: (2020)

Doxorubicin-Induced Cardiac Senescence Is Alleviated Following Treatment with Combined Polyphenols and Micronutrients through Enhancement in Mitophagy
by: Eleonora Foglio, et al.
Published: (2023-11-01)

Fabrication of Nanoformulation Containing Carvedilol and Silk Protein Sericin against Doxorubicin Induced Cardiac Damage in Rats
by: Mohammad Shariq, et al.
Published: (2023-04-01)

COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis
by: Peipei Zhang, et al.
Published: (2023-06-01)

The Imbalance of p53–Park7 Signaling Axis Induces Iron Homeostasis Dysfunction in Doxorubicin‐Challenged Cardiomyocytes
by: Jianan Pan, et al.
Published: (2023-05-01)